O-Desmethyl Lenvatinib | CAS 417717-04-5 - Request Quote
O-Desmethyl Lenvatinib
| SZ CAT No: | SZ-L038041 |
| CAS No | 417717-04-5 |
| Mol.F. | C20H17ClN4O4 |
| Mol.Wt. | 412.8 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
O-Desmethyl Lenvatinib is chemically 4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-hydroxyquinoline-6-carboxamide. O-Desmethyl Lenvatinib is supplied with detailed characterization data compliant with regulatory guideline. O-Desmethyl Lenvatinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenvatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 417717-04-5
Purchase 417717-04-5
Order 417717-04-5
Enquire 417717-04-5
price of 417717-04-5
417717-04-5 Supplier
417717-04-5 Manufacturer
417717-04-5 Exporter
buy high quality O-Desmethyl Lenvatinib
Purchase O-Desmethyl Lenvatinib
O-Desmethyl Lenvatinib suppliers
O-Desmethyl Lenvatinib manufacturers
O-Desmethyl Lenvatinib price
Order O-Desmethyl Lenvatinib
Enquire O-Desmethyl Lenvatinib
O-Desmethyl Lenvatinib cost
O-Desmethyl Lenvatinib Supplier
O-Desmethyl Lenvatinib Distributor
O-Desmethyl Lenvatinib for Method Validation
Lenvatinib Reference Standard
O-Desmethyl Lenvatinib for ANDA Filing
O-Desmethyl Lenvatinib for Forced Degradation Studies
O-Desmethyl Lenvatinib Identification Standards
O-Desmethyl Lenvatinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.